Welcome Guest
Sign In
Register
Research & Development
Quality
Regulatory
Manufacturing
Home
News
Articles
MAGAZINE
Resources
Sponsored Q&A
Whitepapers
eBooks
Infographics
Videos
Webinars
Products
Featured Products
New Products
Events
Featured Article
From pirates to powerhouse
LATEST ARTICLES
Preclinical roadmap to first-in-human
Swimming upstream
2026 cell and gene therapy predictions
From centralized to decentralized
Narrowing the CGT access gap
What sponsors should know about FDA’s platform technology designation
LATEST NEWS
NexCure launches with $19M Series A to deliver outpatient CAR-T
Thursday, March 05, 2026
Prime to seek FDA approval for gene-editing treatment using two-patient trial
Thursday, March 05, 2026
Pierre Fabre requests FDA Type A meeting for twice-rejected T-cell therapy
Wednesday, March 04, 2026
XellSmart secures fourth dual U.S/China regulatory nod for iPSC-derived cell therapy trials
Wednesday, March 04, 2026
FDA lifts remaining hold on Intellia CRISPR-based gene editing trial
Tuesday, March 03, 2026
FDA rejects uniQure data package for Huntington’s gene therapy
Monday, March 02, 2026
Sarepta CEO to step down
Sunday, March 01, 2026
Subscribe to eNewsletters
Keep up with latest in cell and gene therapy news and events, delivered straight to your inbox.
Connect with Us
Subscribe to Magazine
Jan/Feb/Mar 2026 edition now available!
Get started here for your complimentary print or digital subscription
Sign up Now »
Upcoming Events
Cell & Gene Therapy UK 2026
March 9-10, 2026
Advanced Therapies Congress 2026
March 17-18, 2026
7th International Conference on Cell & ...
April 13-15, 2026
Featured Products
ELEVECTA™ Transient Cell Line
Cytiva
HyClone™ Peak Expression Media
Cytiva
LevMixer™ 10 L Single-use Mixing System
Cytiva
ProteanFect™ TuffCell Transfection Kit
Origene
Dual AAV-GFP Controls
Vector Biolabs
Corning® MSCulture Max™ Media
Corning
Xcellerex™ X-platform bioreactors
Cytiva
Fetal Bovine Serum, 500 mL, Australian Origin
Corning